Article ID Journal Published Year Pages File Type
8243683 International Journal of Radiation Oncology*Biology*Physics 2006 7 Pages PDF
Abstract
Conclusion: Preoperative chemoradiotherapy with cetuximab, capecitabine, and weekly irinotecan is feasible and well tolerated. The preliminary efficacy is very promising. Larger phase II trials are ongoing.
Keywords
Related Topics
Physical Sciences and Engineering Physics and Astronomy Radiation
Preview
Phase I trial of cetuximab in combination with capecitabine, weekly irinotecan, and radiotherapy as neoadjuvant therapy for rectal cancer
Authors
, , , , , , , , , , , ,